Amerise Bioscience Financials

BSE: 531681

₹0.82

₹-0.01 (-1.20%)

As on 30-Oct-2026IST

Market cap

₹5 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Income	0.08	--	--	--	9.01	--
Other Income	0.05	0.19	0.04	0.01	0.57	--
Total Income	0.12	0.19	0.04	0.01	9.58	--
Interest Expense	--	0.00	0.00	0.00	0.00	0.00
Operating Expenses	0.19	0.18	0.18	0.13	9.03	0.34
Exceptional Income/Expenses	--	--	--	--	--	--
Profit before Tax	-0.07	0.01	-0.15	-0.12	0.55	-0.34
Taxes	--	0.00	--	--	--	--
Profit after Tax	-0.07	0.01	-0.15	-0.12	0.55	-0.34
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	-0.07	0.01	-0.15	-0.12	0.55	-0.34

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	5.26	5.38	5.37	5.52	5.64	5.09
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	0.09	0.08	--
Current Liabilities	1.56	3.08	0.02	0.04	6.27	0.54
Total Liabilities	6.82	8.46	5.39	5.65	11.99	5.63

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	6.77	8.44	5.37	5.63	5.76	5.61
Current Assets	0.05	0.03	0.02	0.01	6.23	0.02
Total Assets	6.82	8.46	5.39	5.65	11.99	5.63
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	3.07	-0.17	-0.13	0.06	-0.39
Cash Flow from Investing Activities	--	-3.07	0.27	0.13	-0.15	0.39
Cash from Financing Activities	--	--	-0.09	0.01	0.08	--
Net Cash Inflow / Outflow	--	0.00	0.01	0.00	-0.01	-0.01

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	-0.01	0.00	-0.02	-0.02	0.08	-0.05
Cash EPS (₹)	-0.01	0.00	-0.02	-0.02	0.08	-0.05
Adjusted Book Value (₹)	0.80	0.81	0.81	0.84	0.85	0.77
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.46	-0.03	-0.02	0.01	-0.06
Free Cash Flow per Share (₹)	--	0.46	-0.03	-0.02	0.01	-0.06

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	0.15	-2.65	-2.10	10.17	-6.41
ROE (%)	-1.24	0.11	-2.68	-2.13	10.24	-6.41
ROA (%)	-0.87	0.08	-2.65	-1.35	6.24	-5.79
EBIT Margin (%)	-140.51	--	--	--	-0.22	--
Net Margin (%)	-53.23	3.03	-406.96	-1,351.14	5.73	--
Cash Profit Margin (%)	--	--	--	--	6.10	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-68.65	--	--	-100.00	--	--
EBIT Growth (%)	-296.43	0.83	-42.40	-544.44	94.12	-125.65
Net Profit Growth (%)	-265.00	103.90	-22.88	-121.65	262.91	-126.15
EPS Growth (%)	-266.67	104.07	-22.78	-121.66	262.94	-125.66
Book Value Growth (%)	--	0.11	-2.65	-2.11	10.79	-6.21

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-82.09	1,011.11	--	--	16.37	--
Price / Book Value	1.03	1.12	0.81	0.84	1.59	2.14
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-82.16	767.96	-29.76	-39.57	16.48	-32.30
Close Price (₹)	0.81	0.91	0.66	0.70	1.36	1.65
High Price (₹)	1.03	1.45	0.99	1.43	2.73	1.65
Low Price (₹)	0.50	0.55	0.54	0.55	1.30	0.80
Market Cap (₹ Cr)	5.42	--	--	--	8.99	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	--	--	0.02	0.01	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	0.03	0.01	1.48	0.37	0.99	0.04
Quick Ratio	0.03	0.01	1.48	0.37	0.99	0.04
Interest Coverage	--	39.00	-486.00	-1,188.00	1,374.00	-1,631.54

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.